table of content
1 Biosimilars Market Overview
1.1 Product Overview and Scope of Biosimilars
1.2 Biosimilars Segment by Type
1.2.1 Global Biosimilars Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.3 Recombinant Glycosylated Proteins
1.3 Biosimilars Segment by Application
1.3.1 Global Biosimilars Sales Comparison by Application: (2023-2030)
1.3.2 Oncology
1.3.3 Blood Disorders
1.3.4 Growth Hormonal Deficiency
1.3.5 Chronic and Autoimmune Disorders
1.3.6 Others
1.4 Global Biosimilars Market Size Estimates and Forecasts
1.4.1 Global Biosimilars Revenue 2018-2030
1.4.2 Global Biosimilars Sales 2018-2030
1.4.3 Biosimilars Market Size by Region: 2018 Versus 2022 Versus 2030
2 Biosimilars Market Competition by Manufacturers
2.1 Global Biosimilars Sales Market Share by Manufacturers (2018-2023)
2.2 Global Biosimilars Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Biosimilars Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Biosimilars Manufacturing Sites, Area Served, Product Type
2.5 Biosimilars Market Competitive Situation and Trends
2.5.1 Biosimilars Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biosimilars Players Market Share by Revenue
2.5.3 Global Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biosimilars Retrospective Market Scenario by Region
3.1 Global Biosimilars Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Biosimilars Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Biosimilars Market Facts & Figures by Country
3.3.1 North America Biosimilars Sales by Country
3.3.2 North America Biosimilars Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biosimilars Market Facts & Figures by Country
3.4.1 Europe Biosimilars Sales by Country
3.4.2 Europe Biosimilars Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biosimilars Market Facts & Figures by Region
3.5.1 Asia Pacific Biosimilars Sales by Region
3.5.2 Asia Pacific Biosimilars Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Biosimilars Market Facts & Figures by Country
3.6.1 Latin America Biosimilars Sales by Country
3.6.2 Latin America Biosimilars Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Biosimilars Market Facts & Figures by Country
3.7.1 Middle East and Africa Biosimilars Sales by Country
3.7.2 Middle East and Africa Biosimilars Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Biosimilars Historic Market Analysis by Type
4.1 Global Biosimilars Sales Market Share by Type (2018-2023)
4.2 Global Biosimilars Revenue Market Share by Type (2018-2023)
4.3 Global Biosimilars Price by Type (2018-2023)
5 Global Biosimilars Historic Market Analysis by Application
5.1 Global Biosimilars Sales Market Share by Application (2018-2023)
5.2 Global Biosimilars Revenue Market Share by Application (2018-2023)
5.3 Global Biosimilars Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Biosimilars Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Novartis Biosimilars Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Biocon
6.3.1 Biocon Corporation Information
6.3.2 Biocon Description and Business Overview
6.3.3 Biocon Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Biocon Biosimilars Product Portfolio
6.3.5 Biocon Recent Developments/Updates
6.4 Biogen
6.4.1 Biogen Corporation Information
6.4.2 Biogen Description and Business Overview
6.4.3 Biogen Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biogen Biosimilars Product Portfolio
6.4.5 Biogen Recent Developments/Updates
6.5 Fresenius Kabi AG
6.5.1 Fresenius Kabi AG Corporation Information
6.5.2 Fresenius Kabi AG Description and Business Overview
6.5.3 Fresenius Kabi AG Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Fresenius Kabi AG Biosimilars Product Portfolio
6.5.5 Fresenius Kabi AG Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Boehringer Ingelheim Biosimilars Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Merck KgaA
6.6.1 Merck KgaA Corporation Information
6.6.2 Merck KgaA Description and Business Overview
6.6.3 Merck KgaA Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck KgaA Biosimilars Product Portfolio
6.7.5 Merck KgaA Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Mylan Biosimilars Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Eli Lilly Biosimilars Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 Teva Pharmaceutical
6.10.1 Teva Pharmaceutical Corporation Information
6.10.2 Teva Pharmaceutical Description and Business Overview
6.10.3 Teva Pharmaceutical Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Teva Pharmaceutical Biosimilars Product Portfolio
6.10.5 Teva Pharmaceutical Recent Developments/Updates
6.11 Dr. Reddy's Laboratories
6.11.1 Dr. Reddy's Laboratories Corporation Information
6.11.2 Dr. Reddy's Laboratories Biosimilars Description and Business Overview
6.11.3 Dr. Reddy's Laboratories Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Dr. Reddy's Laboratories Biosimilars Product Portfolio
6.11.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.12 Amgen
6.12.1 Amgen Corporation Information
6.12.2 Amgen Biosimilars Description and Business Overview
6.12.3 Amgen Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Amgen Biosimilars Product Portfolio
6.12.5 Amgen Recent Developments/Updates
6.13 Celltrion
6.13.1 Celltrion Corporation Information
6.13.2 Celltrion Biosimilars Description and Business Overview
6.13.3 Celltrion Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Celltrion Biosimilars Product Portfolio
6.13.5 Celltrion Recent Developments/Updates
6.14 Samsung Biologics
6.14.1 Samsung Biologics Corporation Information
6.14.2 Samsung Biologics Biosimilars Description and Business Overview
6.14.3 Samsung Biologics Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Samsung Biologics Biosimilars Product Portfolio
6.14.5 Samsung Biologics Recent Developments/Updates
6.15 Roche
6.15.1 Roche Corporation Information
6.15.2 Roche Biosimilars Description and Business Overview
6.15.3 Roche Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Roche Biosimilars Product Portfolio
6.15.5 Roche Recent Developments/Updates
6.16 Probiomed
6.16.1 Probiomed Corporation Information
6.16.2 Probiomed Biosimilars Description and Business Overview
6.16.3 Probiomed Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Probiomed Biosimilars Product Portfolio
6.16.5 Probiomed Recent Developments/Updates
6.17 Apotex
6.17.1 Apotex Corporation Information
6.17.2 Apotex Biosimilars Description and Business Overview
6.17.3 Apotex Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Apotex Biosimilars Product Portfolio
6.17.5 Apotex Recent Developments/Updates
6.18 Chong Kun Dang
6.18.1 Chong Kun Dang Corporation Information
6.18.2 Chong Kun Dang Biosimilars Description and Business Overview
6.18.3 Chong Kun Dang Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Chong Kun Dang Biosimilars Product Portfolio
6.18.5 Chong Kun Dang Recent Developments/Updates
6.19 JCR Pharmaceuticals
6.19.1 JCR Pharmaceuticals Corporation Information
6.19.2 JCR Pharmaceuticals Biosimilars Description and Business Overview
6.19.3 JCR Pharmaceuticals Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.19.4 JCR Pharmaceuticals Biosimilars Product Portfolio
6.19.5 JCR Pharmaceuticals Recent Developments/Updates
6.20 Gan & Lee Pharmaceuticals
6.20.1 Gan & Lee Pharmaceuticals Corporation Information
6.20.2 Gan & Lee Pharmaceuticals Biosimilars Description and Business Overview
6.20.3 Gan & Lee Pharmaceuticals Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Gan & Lee Pharmaceuticals Biosimilars Product Portfolio
6.20.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
6.21 Gedeon Richter
6.21.1 Gedeon Richter Corporation Information
6.21.2 Gedeon Richter Biosimilars Description and Business Overview
6.21.3 Gedeon Richter Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Gedeon Richter Biosimilars Product Portfolio
6.21.5 Gedeon Richter Recent Developments/Updates
6.22 Biocad
6.22.1 Biocad Corporation Information
6.22.2 Biocad Biosimilars Description and Business Overview
6.22.3 Biocad Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Biocad Biosimilars Product Portfolio
6.22.5 Biocad Recent Developments/Updates
6.23 Coherus Bioscience
6.23.1 Coherus Bioscience Corporation Information
6.23.2 Coherus Bioscience Biosimilars Description and Business Overview
6.23.3 Coherus Bioscience Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Coherus Bioscience Biosimilars Product Portfolio
6.23.5 Coherus Bioscience Recent Developments/Updates
6.24 Stada Arzneimittel AG
6.24.1 Stada Arzneimittel AG Corporation Information
6.24.2 Stada Arzneimittel AG Biosimilars Description and Business Overview
6.24.3 Stada Arzneimittel AG Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Stada Arzneimittel AG Biosimilars Product Portfolio
6.24.5 Stada Arzneimittel AG Recent Developments/Updates
7 Biosimilars Manufacturing Cost Analysis
7.1 Biosimilars Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biosimilars
7.4 Biosimilars Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biosimilars Distributors List
8.3 Biosimilars Customers
9 Biosimilars Market Dynamics
9.1 Biosimilars Industry Trends
9.2 Biosimilars Market Drivers
9.3 Biosimilars Market Challenges
9.4 Biosimilars Market Restraints
10 Global Market Forecast
10.1 Biosimilars Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biosimilars by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Biosimilars by Type (2023-2030)
10.2 Biosimilars Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biosimilars by Application (2023-2030)
10.2.2 Global Forecasted Revenue of Biosimilars by Application (2023-2030)
10.3 Biosimilars Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biosimilars by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Biosimilars by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
